Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Chinese Patent Office
Express Scripts
Boehringer Ingelheim
Harvard Business School

Generated: July 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 074415

« Back to Dashboard

NDA 074415 describes SUCRALFATE, which is a drug marketed by Mylan Ireland Ltd and Teva and is included in two NDAs. It is available from eighteen suppliers. Additional details are available on the SUCRALFATE profile page.

The generic ingredient in SUCRALFATE is sucralfate. There are fourteen drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the sucralfate profile page.
Summary for 074415
Applicant:Mylan Ireland Ltd
Therapeutic Class:Gastrointestinal Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 074415
Medical Subject Heading (MeSH) Categories for 074415
Suppliers and Packaging for NDA: 074415
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SUCRALFATE sucralfate TABLET;ORAL 074415 ANDA Golden State Medical Supply, Inc. 60429-297 N 60429-297-01
SUCRALFATE sucralfate TABLET;ORAL 074415 ANDA Golden State Medical Supply, Inc. 60429-297 N 60429-297-05

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength1GM
Approval Date:Jun 8, 1998TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Harvard Business School
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.